Compare SHEN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHEN | YDES |
|---|---|---|
| Founded | 1902 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 635.1M | 543.0M |
| IPO Year | 1994 | N/A |
| Metric | SHEN | YDES |
|---|---|---|
| Price | $13.26 | $2.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $26.00 | N/A |
| AVG Volume (30 Days) | ★ 519.6K | 34.7K |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $357,854,000.00 | N/A |
| Revenue This Year | $7.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.08 | N/A |
| 52 Week Low | $9.67 | $1.70 |
| 52 Week High | $17.35 | $25.00 |
| Indicator | SHEN | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 55.19 | 48.98 |
| Support Level | $10.94 | $1.93 |
| Resistance Level | $13.44 | $2.93 |
| Average True Range (ATR) | 0.68 | 0.32 |
| MACD | 0.31 | 0.04 |
| Stochastic Oscillator | 82.50 | 48.84 |
Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.